Evidence map›Paper›PMID 34268073›Full record

ArticleGland surgery2021

The association between molecular type and prognosis of patients with stage IV breast cancer: an observational study based on SEER database.

Lingmi Hou, Mengxue Qiu, Maoshan Chen, Fangfang Li, Junyan Li, Shishan Deng, Yahan Yang, Zhenggui Du, Hongwei Yang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gland surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. HRDrugs in context · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Lingmi HouDepartment of Breast and Thyroid Surgery, Biological Targeting Laboratory of Breast Cancer, Academician (expert) Workstation, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Mengxue QiuDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Maoshan ChenDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Fangfang LiDepartment of Breast and Thyroid Surgery, Affiliated Suining Central Hospital of Chongqing Medical University, Suining, China.
Junyan LiDepartment of Breast Surgery, People's Hospital of Deyang City, Deyang, China.
Shishan DengDepartment of Breast and Thyroid Surgery, Biological Targeting Laboratory of Breast Cancer, Academician (expert) Workstation, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Yahan YangClinical Medicine, Queen Mary College of Nanchang University, Nanchang, China.
Zhenggui DuDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Hongwei YangDepartment of Breast and Thyroid Surgery, Affiliated Suining Central Hospital of Chongqing Medical University, Suining, China.
Affiliated Hospital of North Sichuan Medical College · CNChongqing Medical University · CNSichuan University · CNNanchang University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMolecular subtype, the basis for personalized treatment of breast cancer, is of great value in evaluating prognosis and guiding treatment of early-stage breast cancer. However, its value in stage IV patients remains unclear. In this study, we investigated the association between molecular subtype and prognosis of

methodsWe retrospectively analyzed

resultsA total of 11,974 patients were included in this study, among which 7,100 (59.30%) patients were of HR

conclusionsMolecular subtypes were closely associated with the prognosis of

Indexed as

breast cancerMolecular typeprognosisstage IVSurveillance, Epidemiology, and End Results program (SEER program)

Identifiers

PMID34268073
PMCPMC8258870
OpenAlexW3168085008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.